13F filer · CIK 2012383 ↗
BlackRock
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$3.12T
−16% on the quarter before
Positions
5,919
336 new · 264 sold out
Top 10
18.9%
of the value
Est. gain
−$595.10B
on stocks held all quarter
Est. return
−16.4%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from BlackRock's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Warner Bros Discovery Inc~$2.23BNew · 0.0% → 0.1%+166,503,034 shares
- Linde Plc~$2.16BAdded · 0.2% → 0.3%+7,526,120 shares
- Pfizer Inc~$1.42BAdded · 0.6% → 0.7%+27,068,406 shares
- Unitedhealth Group Inc~$1.38BAdded · 0.9% → 1.2%+2,693,242 shares
- Chevron Corp New~$1.34BAdded · 0.6% → 0.6%+9,258,792 shares
- Coca Cola Co~$1.30BAdded · 0.5% → 0.6%+20,723,906 shares
- Vici Pptys Inc~$1.12BAdded · 0.0% → 0.1%+37,670,369 shares
- Exxon Mobil Corp~$1.06BAdded · 0.6% → 0.8%+12,348,128 shares
- Merck & Co Inc~$1.05BAdded · 0.5% → 0.6%+11,545,571 shares
- Keurig Dr Pepper Inc~$910.3MAdded · 0.0% → 0.1%+25,721,639 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Cerner Corp~$2.23BSold out · 0.1% → 0.0%−23,841,125 shares
- SPDR S&P 500 ETF TrPUT~$2.10BCut · 0.1% → 0.0%−5,559,300 underlying
- Baidu~$1.20BCut · 0.0% → 0.0%−8,097,361 shares
- Aspen Technology Inc~$1.10BSold out · 0.0% → 0.0%−6,645,133 shares
- Fortinet~$933.5MCut · 0.1% → 0.1%−16,498,619 shares
- Alphabet~$850.4MCut · 1.4% → 1.3%−388,746 shares
- Nxp Semiconductors N V~$850.1MCut · 0.1% → 0.1%−5,742,581 shares
- Amgen Inc~$779.2MCut · 0.3% → 0.4%−3,202,618 shares
- Peoples United Financial Inc~$733.1MSold out · 0.0% → 0.0%−36,670,981 shares
- Invesco Qqq TrPUT~$697.4MCut · 0.0% → 0.0%−2,488,300 underlying
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.1% · price −21.7% | 4.5% | $140.64B | −$38.94B | ||||||||
| MicrosoftCOM · shares −0.2% · price −16.7% | 4.3% | $134.21B | −$26.90B | ||||||||
| AmazonCOM · shares +0.8% · price −34.8% | 2.0% | $62.39B | −$33.10B | ||||||||
| AlphabetCAP STK CL A · shares +0.4% · price −21.6% | 1.5% | $45.29B | −$12.46B | ||||||||
| AlphabetCAP STK CL C · shares −2.0% · price −21.7% | 1.3% | $40.75B | −$11.28B | ||||||||
| TeslaCOM · shares +0.2% · price −37.5% | 1.2% | $37.29B | −$22.33B | ||||||||
| Unitedhealth Group IncCOM · shares +3.9% · price +0.7% | 1.2% | $36.83B | +$252.6M | ||||||||
| Johnson & JohnsonCOM · shares +2.3% · price +0.2% | 1.2% | $36.46B | +$56.2M | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +1.9% · price −22.6% | 0.91% | $28.46B | −$8.17B | ||||||||
| NvidiaCOM · shares −1.0% · price −44.4% | 0.87% | $27.16B | −$21.73B | ||||||||
| Ishares TrCORE S&P500 ETF · shares −1.5% · price −16.4% | 0.86% | $26.77B | −$5.26B | ||||||||
| Exxon Mobil CorpCOM · shares +4.5% · price +3.7% | 0.79% | $24.62B | +$839.0M | ||||||||
| Visa Inc.COM CL A · shares −2.3% · price −11.2% | 0.78% | $24.45B | −$3.09B | ||||||||
| MetaCL A · shares +1.1% · price −27.5% | 0.78% | $24.44B | −$9.16B | ||||||||
| Procter And Gamble CoCOM · shares +3.9% · price −5.9% | 0.74% | $23.21B | −$1.40B | ||||||||
| Pfizer IncCOM · shares +6.6% · price +1.3% | 0.73% | $22.82B | +$269.3M | ||||||||
| Jpmorgan Chase & CoCOM · shares −2.0% · price −17.4% | 0.71% | $22.25B | −$4.68B | ||||||||
| Eli LillyCOM · shares −0.4% · price +13.2% | 0.66% | $20.67B | +$2.41B | ||||||||
| Abbvie IncCOM · shares +3.9% · price −5.5% | 0.66% | $20.63B | −$1.16B | ||||||||
| MastercardCL A · shares −1.5% · price −11.7% | 0.65% | $20.30B | −$2.70B | ||||||||
| Chevron Corp NewCOM · shares +7.3% · price −11.1% | 0.64% | $19.80B | −$2.30B | ||||||||
| Home Depot IncCOM · shares −0.5% · price −8.4% | 0.63% | $19.67B | −$1.80B | ||||||||
| Merck & Co IncCOM · shares +5.7% · price +11.1% | 0.63% | $19.66B | +$1.86B | ||||||||
| Coca Cola CoCOM · shares +7.4% · price +1.5% | 0.61% | $18.86B | +$254.0M | ||||||||
| Pepsico IncCOM · shares +3.3% · price −0.4% | 0.57% | $17.91B | −$74.9M | ||||||||
| Total · 5,919 positions | 100% | $3.12T | −$595.10B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 5,260 stocks held throughout, down $595.10B (−16.4%).
- Eli Lilly+$2.41B+13%
- Merck & Co Inc+$1.86B+11%
- Exxon Mobil Corp+$839.0M+4%
- IBM+$743.8M+9%
- Cigna Corp New+$669.7M+10%
- Nvidia−$21.73B−44%
- Tesla−$22.33B−38%
- Microsoft−$26.90B−17%
- Amazon20:1 split−$33.10B−35%
- Apple−$38.94B−22%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 63 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | $6.73T+18% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $5.72T−3% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $5.92T+4% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $5.71T+9% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $5.25T+10% | SEC ↗ |
| Q1 2025 | May 2, 2025 | $4.76T−4% | SEC ↗ |
| Q4 2024 | Feb 7, 2025 | $4.94T+4% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $4.76T+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $4.42T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $4.30T+10% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $3.92T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $3.48T−4% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $3.63T+7% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $3.39T+6% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $3.19T+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $2.94T−6% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $3.12T−16% | SEC ↗ |
| Q1 2022 | May 12, 2022 | $3.71T−6% | SEC ↗ |
| Q4 2021 | Feb 10, 2022 (amended) | $3.93T+10% | SEC ↗ |
| Q3 2021 | Nov 9, 2021 | $3.57T−1% | SEC ↗ |
| Q2 2021 | Aug 11, 2021 | $3.59T+6% | SEC ↗ |
| Q1 2021 | May 7, 2021 | $3.40T+9% | SEC ↗ |
| Q4 2020 | Feb 5, 2021 | $3.13T+16% | SEC ↗ |
| Q3 2020 | Nov 6, 2020 | $2.71T+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.51T+23% | SEC ↗ |
| Q1 2020 | May 1, 2020 | $2.04T−22% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $2.61T+10% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $2.38T+2% | SEC ↗ |
| Q2 2019 | Aug 22, 2019 (amended) | $2.34T+4% | SEC ↗ |
| Q1 2019 | May 9, 2019 | $2.24T+13% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.98T−14% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $2.31T+6% | SEC ↗ |
| Q2 2018 | Aug 9, 2018 | $2.17T+4% | SEC ↗ |
| Q1 2018 | May 9, 2018 | $2.09T−0% | SEC ↗ |
| Q4 2017 | Feb 9, 2018 | $2.10T+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $1.98T+5% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.89T+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $1.82T+2,478% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $70.66B+1% | SEC ↗ |
| Q3 2016 | Nov 8, 2016 | $69.66B+5% | SEC ↗ |
| Q2 2016 | Aug 10, 2016 | $66.46B+7% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $62.17B | SEC ↗ |